Skip to content
Tuesday, November 17, 2026
Spin Plus Empire

The Zimbabwean Government Declines ‘Lopsided’ American Healthcare Assistance Deal Due to Information Concerns

Medical funding illustration
The proposed American financial assistance was intended for programmes for treating and preventing HIV/Aids, tuberculosis, and malaria.

Zimbabwe has rejected a substantial US healthcare agreement worth $367m (£272m) spanning five years because of Washington's request for sensitive biological samples.

This move came to light after a internal memorandum dated December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "skewed".

An official spokesperson has since explained that the United States was requesting genetic material for scientific study and profit but was not willing to share the benefits from future medical innovations.

"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy noted the United States had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A physicians' group in Zimbabwe has appealed for further negotiations to secure a deal acceptable to both sides so the nation's critical HIV programme can be sustained.

Wider Background

This rejection comes after a similar case in neighbouring Kenya, where a high court blocked a similar health funding agreement following concerns were filed about the security of citizens' health data.

After returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).

The agency had overseen aid for the US government, but Trump claimed its expenditure was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and accountability.

According to reports, Sixteen African countries have to date agreed to these new agreements, constituting over $18.3bn of fresh investment.

Details of the Declined Deal

The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"It is our view this collaboration could have provided immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via US-supported initiatives," Tremont added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unequal".

"Our nation was requested to share its genetic material and health information over an extended period, with no corresponding assurance of access to any scientific breakthroughs – like new medicines or tests – that might result from that shared data," Mangwana explained.

"Effectively, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be accessible to our population should a future pandemic arise."

Sovereignty and International Frameworks

He also noted that the American exit from the global health body and its pursuit of bilateral health agreements were upending structures already set up through the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.

"This framework is designed to guarantee that when a country contributes its samples, the resulting advantages – such as vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to create them."

Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.

"We encourage ongoing dialogue with our American counterparts on how future co-operation could be structured in a way that respects the independence and dignity of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but recommended that talks need to persist given that much of the nation's HIV programmes relied on international support.

"Where specific concerns exist, such as those relating to data governance or implementation frameworks, these can often be resolved through technical clarification and negotiated safeguards," it added.

The situation underscores the ongoing tensions between accepting crucial international aid and safeguarding national sovereignty in an ever more interconnected world.

About the author

Sarah Holmes

Maya Rodriguez is a seasoned digital marketer with over 10 years of experience, specializing in content creation and brand storytelling.

Spin Plus Empire

Type to search articles.